BCEIE › News › EXPLEOSOL

M&A

Expleo Solutions: Reference to the Company's intimation letter dated May 13, 2026 and pursuant to the requirement of…

Expleo Solutions (EXPLEOSOL) filed a disclosure titled "Reference to the Company's intimation letter dated May 13, 2026 and pursuant to the requirement of Regulation 30 of the SEBI (LODR) Regulations, 2015, we would like to inform you…". The company is…

BCEIE News Desk · Published 9 Oct 2026, 03:38 pm IST · Filing received 9 Oct 2026, 03:23 pm IST

What happened

Expleo Solutions (EXPLEOSOL) filed a disclosure with the exchanges on 9 October 2026 at 03:23 PM titled "Reference to the Company's intimation letter dated May 13, 2026 and pursuant to the requirement of Regulation 30 of the SEBI (LODR) Regulations, 2015, we would like to inform you…".

Company snapshot

Expleo Solutions is a small-cap company, with a market value of about ₹1,339 crore.

The stock last traded at ₹862.7, against a 52-week range of ₹640–₹1,175.1 (26.6% below the high).

Before this filing the shares had moved −4.1% over the month and +4.1% over three months. Average daily turnover over the last 20 sessions was about ₹1.46 crore.

Promoters held 71.05% at the end of Q1 FY27. Foreign institutions owned 0.13% and domestic institutions 0.12%.

Quarterly results (consolidated, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY2626020.413.16
Q2 FY2628339.825.62
Q3 FY2627922.114.26
Q4 FY2628649.326.85
Q1 FY2729234.222.02

What history shows

BCEIE has no earlier m&a filing from this company on record since May 2026.

Market-wide, 2,013 m&a filings with an impact score of 50 or more saw an average next-day move of +0.4%, with 49% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

  • Regulatory approvals, completion of the deal and its effect on revenue and margins.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.